European Guideline on IgG4-related digestive disease – UEG and SGF evidence-based recommendations:

Published on Jun 18, 2020in United European gastroenterology journal3.549
· DOI :10.1177/2050640620934911
J-Matthias Löhr10
Estimated H-index: 10
(Karolinska University Hospital),
Ulrich Beuers66
Estimated H-index: 66
(UvA: University of Amsterdam)
+ 32 AuthorsHeiko Witt40
Estimated H-index: 40
(TUM: Technische Universität München)
Sources
Abstract
The overall objective of these guidelines is to provide evidence-based recommendations for the diagnosis and management of immunoglobulin G4 (IgG4)-related digestive disease in adults and children. IgG4-related digestive disease can be diagnosed only with a comprehensive work-up that includes histology, organ morphology at imaging, serology, search for other organ involvement, and response to glucocorticoid treatment. Indications for treatment are symptomatic patients with obstructive jaundice, abdominal pain, posterior pancreatic pain, and involvement of extra-pancreatic digestive organs, including IgG4-related cholangitis. Treatment with glucocorticoids should be weight-based and initiated at a dose of 0.6-0.8 mg/kg body weight/day orally (typical starting dose 30-40 mg/day prednisone equivalent) for 1 month to induce remission and then be tapered within two additional months. Response to initial treatment should be assessed at week 2-4 with clinical, biochemical and morphological markers. Maintenance treatment with glucocorticoids should be considered in multi-organ disease or history of relapse. If there is no change in disease activity and burden within 3 months, the diagnosis should be reconsidered. If the disease relapsed during the 3 months of treatment, immunosuppressive drugs should be added.
📖 Papers frequently viewed together
References225
Newest
#1Marco LanzillottaH-Index: 1
#1Marco Lanzillotta (UniSR: Vita-Salute San Raffaele University)H-Index: 14
Last. Jonas Rosendahl (MLU: Martin Luther University of Halle-Wittenberg)H-Index: 9
view all 8 authors...
Introduction: Treatment of autoimmune pancreatitis (AIP) is based solely on consensus and has yet to become standardized. Consequently, therapeutic regimens vary greatly between countries and centres, and largely depend on the experience of the physician. At this moment, the optimal regimen for inducing disease remission and preventing relapse is unknown. Objectives: The primary objective of this study is to describe current treatment regimens used in Europe, and to compare their effectiveness i...
2 CitationsSource
#1Elsemieke de VriesH-Index: 5
#2Floor TielbekeH-Index: 1
Last. Ulrich BeuersH-Index: 66
view all 11 authors...
Abstract Background and Aims IgG4-related disease (IgG4-RD) of the biliary tract and pancreas is often difficult to distinguish from pancreatobiliary cancer. Misdiagnosis may result in unnecessary major surgical interventions or chemotherapy. The blood IgG4/IgG RNA ratio was reported to discriminate IgG4-RD from Primary Sclerosing Cholangitis or pancreatobiliary cancer with high accuracy. This study aimed to prospectively assess the diagnostic accuracy of blood IgG4/IgG RNA ratio for differentia...
3 CitationsSource
#1Seyoun Park (Johns Hopkins University)H-Index: 13
#2Linda Chi Hang Chu (Johns Hopkins University)H-Index: 7
Last. Satomi Kawamoto (Johns Hopkins University)H-Index: 38
view all 14 authors...
PURPOSE: The purpose of this study was to determine whether computed tomography (CT)-based machine learning of radiomics features could help distinguish autoimmune pancreatitis (AIP) from pancreatic ductal adenocarcinoma (PDAC). MATERIALS AND METHODS: Eighty-nine patients with AIP (65 men, 24 women; mean age, 59.7+/-13.9 [SD] years; range: 21-83 years) and 93 patients with PDAC (68 men, 25 women; mean age, 60.1+/-12.3 [SD] years; range: 36-86 years) were retrospectively included. All patients ha...
15 CitationsSource
#1Zachary S. Wallace (Harvard University)H-Index: 25
#2Ray Naden (McMaster University)H-Index: 6
Last. John H. Stone (Harvard University)H-Index: 76
view all 20 authors...
IgG4-related disease (IgG4-RD) can cause fibroinflammatory lesions in nearly any organ. Correlation among clinical, serological, radiological and pathological data is required for diagnosis. This work was undertaken to develop and validate an international set of classification criteria for IgG4-RD. An international multispecialty group of 86 physicians was assembled by the American College of Rheumatology (ACR) and the European League Against Rheumatism (EULAR). Investigators used consensus exe...
109 CitationsSource
#1Pei Xiang (SYSU: Sun Yat-sen University)H-Index: 2
#2Xiaoling Zhang (SYSU: Sun Yat-sen University)H-Index: 2
Last. Shi-Ting Feng (SYSU: Sun Yat-sen University)H-Index: 17
view all 8 authors...
The co-occurrence of type 1 autoimmune pancreatitis (AIP) and pancreatic tumor (PaT) has been previously reported. Pure AIP cases have favorable prognosis and are primarily treated with steroids, while AIP cases with PaT are associated with poor prognosis where the primary management is pancreatic resection. However, it’s a challenge to timely identify the concurrent PaT in AIP because of their similar clinical and radiological manifestations. We retrospectively reviewed the data in two medical ...
5 CitationsSource
#1Heithem Soliman (Paris Diderot University)H-Index: 1
#2Marie-Pierre Vullierme (Paris Diderot University)H-Index: 37
Last. Vinciane Rebours (Paris Diderot University)H-Index: 34
view all 7 authors...
Background and aimsSteroid therapy is the first-line treatment for autoimmune pancreatitis but relapses are frequent. The aims were to assess the efficacy and the safety of immunomodulator treatmen...
10 CitationsSource
#1Ayana Okamoto (Kindai University)H-Index: 6
#2Tomohiro Watanabe (Kindai University)H-Index: 35
Last. Masatoshi Kudo (Kindai University)H-Index: 88
view all 5 authors...
: Autoimmune pancreatitis (AIP) is now considered a pancreatic manifestation of a newly proposed disease condition, IgG4-related disease (IgG4-RD). IgG4-RD is characterized by enhanced IgG4 antibody responses and multiple organ involvements. Recent epidemiological studies have addressed the incidence of cancer in patients with AIP and/or IgG4-RD. Surprisingly, a significant number of AIP patients were detected with cancer at or within one year of the diagnosis of AIP. Furthermore, around 50% of ...
7 CitationsSource
#1Matteo Tacelli (University of Palermo)H-Index: 5
#2Ciro Celsa (University of Palermo)H-Index: 7
Last. Calogero Cammà (University of Palermo)H-Index: 61
view all 9 authors...
Background & Aims Risk for relapse after induction of remission with steroid therapy has been studied extensively in patients with autoimmune pancreatitis (AIP), but findings have been equivocal. We performed a systematic review and meta-analysis to estimate the relapse rate of AIP after initial remission after steroid treatment and to identify factors associated with relapse. Methods Three reviewers searched MEDLINE, SCOPUS, and EMBASE until July 2018 to identify studies on rate of relapse of A...
9 CitationsSource
#1Yusuf Aydemir (Eskişehir Osmangazi University)H-Index: 1
#2Zuhal Akçören (Hacettepe University)H-Index: 19
Last. Aysel Yüce (Hacettepe University)H-Index: 21
view all 6 authors...
BACKGROUND AND AIM: We aimed to examine the frequency and the characteristics of immunoglobulin G4 (IgG4)-associated autoimmune hepatitis among pediatric patients with autoimmune hepatitis. METHODS: Immunostaining for IgG and IgG4 was performed in liver biopsies of 40 pediatric patients with autoimmune hepatitis. The patients with more than 10 IgG4-positive plasma cells/high-power field were defined as IgG4-associated autoimmune hepatitis. Clinic, laboratory, and histopathological results were c...
7 CitationsSource
#1Kshitij S. Arora (Harvard University)H-Index: 12
#2Miguel Rivera (Harvard University)H-Index: 37
Last. Vikram Deshpande (Harvard University)H-Index: 100
view all 4 authors...
AIMS: The pathological diagnosis of IgG4-related disease (IgG4-RD) relies on histology, IgG4-positive cells, and an increased IgG4/IgG ratio. Small biopsies from patients with a presumptive diagnosis of IgG4-RD often fail to meet consensus histological criteria. The aims of this study were to evaluate consecutive small biopsies from patients with a presumptive diagnosis of IgG4-RD, and to assess the significance of the pathological findings. METHODS AND RESULTS: We evaluated 55 small biopsies fr...
12 CitationsSource
Cited By13
Newest
#2J.-Matthias LöhrH-Index: 18
Source
Objectives: IgG4-related disease (IgG4-RD) is a chronic fibro-inflammatory disorder affecting virtually any organ. Type 1 autoimmune (type 1 AIP) is its pancreatic manifestation. To date, steroids are considered the first-line pancreatitis treatment. The CD20-binding antibody rituximab (RTX) appears a promising steroid-sparing therapy, although long-term data are lacking. We aimed to bridge this gap with a cohort of IgG4-RD patients treated with RTX and to assess the potential value of the Respo...
Source
#1Matteo TacelliH-Index: 5
#2Piera ZaccariH-Index: 3
Last. Paolo Giorgio ArcidiaconoH-Index: 33
view all 4 authors...
The diagnosis of autoimmune pancreatitis (AIP) is often challenging and distinguishing it from chronic pancreatitis or pancreatic cancer (PC) could be very difficult. In particular, AIP can present at CT scan, MRI or endoscopic ultrasound (EUS) as a focal mass, sometimes with no other specific peculiarities. Furthermore, current international guidelines1 2 consider EUS only as a way to obtain cyto-histological specimens to exclude malignancy, regardless to its diagnostic capacity based on morpho...
Source
#1Livia Archibugi (UniSR: Vita-Salute San Raffaele University)H-Index: 12
#2Katarzyna M. Pawlak (Ministry of Interior (Saudi Arabia))H-Index: 2
Last. Diogo LibânioH-Index: 11
view all 3 authors...
Source
#2Tatsunori SatohH-Index: 4
Last. Hiroyuki OnoH-Index: 18
view all 18 authors...
Abstract Background/objectives International consensus diagnostic criteria (ICDC) include characteristic images of autoimmune pancreatitis (AIP); however, reports on atypical cases are increasing. The aims of this study were to compare CT findings between AIP and pancreatic cancer (PC), and to analyze type 1 AIPs showing atypical images. Methods Five-phase CT images were compared between 80 type 1-AIP lesions and 80 size- and location-matched PCs in the case-control study. Atypical AIPs were dia...
Source
#1Søren Schou Olesen (AAU: Aalborg University)H-Index: 25
#2Laust Hvas Mortensen (UCPH: University of Copenhagen)H-Index: 28
Last. Janne Schurmann Tolstrup (University of Southern Denmark)H-Index: 41
view all 9 authors...
Source
#1Per Hedenström (University of Gothenburg)H-Index: 5
#2Björn Lindkvist (University of Gothenburg)H-Index: 41
Source
#1Miroslav Vujasinovic (KI: Karolinska Institutet)H-Index: 1
#1Miroslav Vujasinovic (KI: Karolinska Institutet)H-Index: 11
Last. Johannes-Matthias Löhr (KI: Karolinska Institutet)H-Index: 11
view all 13 authors...
Source